Casticin From Sanse Powder‐ In Vitro Release Medium Inhibits FAK / PI3K / AKT Phosphorylation Reducing Synovial Senescence and Alleviates Inflammation in Knee Osteoarthritis
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Jiangyu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Osteoarthritis, Knee, Inflammation. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Special Program for Outstanding Young PhD Training, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Third Batch of High-level Academic Talent, Jiangsu Provincial Hospital of Traditional Chinese Medicine.
Abstract (Originalsprache)
Sanse Powder (SSP) has been shown to be effective in the clinical treatment of knee osteoarthritis (KOA), although its active components and underlying mechanisms remain unclear. In this study, we collected the in vitro release medium of SSP (SSP‐IVRM) using an in vitro release test and evaluated its pharmacological effects in a KOA rat model. Ultra‐high‐performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) was used to identify active constituents in SSP‐IVRM, while network pharmacology and molecular docking were applied to screen key compounds and molecular targets. In vivo and in vitro experiments using histological staining and molecular biology techniques were performed to investigate the effects of casticin (CAS), a major component of SSP‐IVRM, on KOA‐related synovitis. UHPLC–MS/MS identified CAS, monocerin, and chlorogenic acid as major components. Network pharmacology and molecular docking associated these compounds with PI3K signalling and cellular senescence. CAS significantly improved synovial pathology, reduced pro‐inflammatory cytokines and chemokines, modulated fibrosis‐ and senescence‐related genes and proteins, and decreased synovial fibroblast senescence. Transcriptomic analysis further implicated cell adhesion and the PI3K–AKT pathway. Additional experiments demonstrated that CAS alleviates KOA‐related inflammation and cellular senescence by inhibiting FAK/PI3K/AKT phosphorylation. These findings indicate that CAS in SSP‐IVRM reduces synovial fibroblast senescence and inflammation through inhibition of the FAK/PI3K/AKT signalling pathway, thereby exerting therapeutic effects against KOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
- The First College of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Jiangsu Provincial Engineering Research Center of TCM External Medication Development and Application, Nanjing, China.
- Nanjing University of Chinese Medicine Clinical Research Institute for Knee Osteoarthritis, Nanjing, China.
ORCID-Profile: Peng Wu, Peimin Wang, Songjiang Yin, Jun Mao
Förderung
- National Natural Science Foundation of China
- Special Program for Outstanding Young PhD Training, Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Third Batch of High-level Academic Talent, Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Fourth Batch of Outstanding Clinical Talent in Traditional Chinese Medicine, Jiangsu Province
- Key Project of the Jiangsu Provincial Traditional Chinese Medicine Science and Technology Development Plan
- Jiangsu Provincial Medical Key Discipline (Laboratory) Cultivation Unit
- Clinical Medical Innovation Center for Knee Osteoarthritis of TCM, Jiangsu Provincial Hospital of Chinese Medicine
- Knee Osteoarthritis Specialized Clinical Research Institute, Nanjing University of Chinese Medicine
Zitieren
APA
Liu, J., Wu, P., Jiang, R., Jie, L., Shi, L., Fu, H., Wei, Y., Liu, D., Wang, P., Yin, S., & Mao, J. (2026). Casticin From Sanse Powder‐ In Vitro Release Medium Inhibits FAK / PI3K / AKT Phosphorylation Reducing Synovial Senescence and Alleviates Inflammation in Knee Osteoarthritis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71391
Vancouver
Liu J, Wu P, Jiang R, Jie L, Shi L, Fu H, et al. Casticin From Sanse Powder‐ In Vitro Release Medium Inhibits FAK / PI3K / AKT Phosphorylation Reducing Synovial Senescence and Alleviates Inflammation in Knee Osteoarthritis. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71391
BibTeX
@article{Liu2026,
author = {Liu, Jiangyu and Wu, Peng and Jiang, Rui and Jie, Lishi and Shi, Lei and Fu, Houyu and Wei, Yibao and Liu, Deren and Wang, Peimin and Yin, Songjiang and Mao, Jun},
title = {Casticin From Sanse Powder‐ In Vitro Release Medium Inhibits FAK / PI3K / AKT Phosphorylation Reducing Synovial Senescence and Alleviates Inflammation in Knee Osteoarthritis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71391}
}
EUVIMED